GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Matricelf Ltd (OTCPK:MTRLF) » Definitions » Issuance of Debt

Matricelf (Matricelf) Issuance of Debt : $0.00 Mil (TTM As of . 20)


View and export this data going back to 2021. Start your Free Trial

What is Matricelf Issuance of Debt?

Matricelf's Issuance of Debt for the six months ended in . 20 was $0.00 Mil.

Matricelf's Issuance of Debt for the trailing twelve months (TTM) ended in . 20 was $0.00 Mil.


Matricelf Issuance of Debt Historical Data

The historical data trend for Matricelf's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Matricelf Issuance of Debt Chart

Matricelf Annual Data
Trend
Issuance of Debt

Matricelf Semi-Annual Data
Issuance of Debt

Matricelf Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Issuance of Debt for the trailing twelve months (TTM) ended in . 20 was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Matricelf Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Matricelf's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Matricelf (Matricelf) Business Description

Traded in Other Exchanges
Address
Golda Meir 3, Ness Ziona, ISR, 6701838
Matricelf Ltd is engaged in research and development in the field of medicine and tissue engineering. It is a pioneering biotechnology company developing a platform for autologous matrix and cells implants for a wide range of medical conditions.

Matricelf (Matricelf) Headlines